Therapist Insights / Therapy Privacy
Mental health for CEOs, and why discretion matters.
News about a chief executive moves faster than news about anyone else in the building. That is why the first question a CEO asks is almost never about therapy itself. It is about who could learn of it, through which document, and with how much warning. Those are answerable questions, and the answers are far more specific than the reassurance usually offered.
THE QUICK TAKEAWAY
Private-pay care removes the single largest disclosure surface in ordinary treatment, which is the claim. No claim is filed, no diagnosis reaches a payer, and no reviewer at an insurer holds a file on a chief executive. Private pay does not erase the clinician's own record, and it does not override a court order, a mandatory report, or a duty-to-protect obligation defined by state law. CEREVITY names those limits before a first session rather than after one, because a CEO deciding whether to start is weighing exposure, not comfort, and a promise of absolute confidentiality from anyone should end the conversation rather than begin it.
§01 / 09 / Definition
The surfaces where a CEO is exposed.
Chief executives carry disclosure surfaces that most patients never encounter: insurance underwritten on their life, board discussion of succession, an annual officer questionnaire, and a calendar somebody else maintains. CEREVITY treats each surface as a separate question, because the confidentiality of a clinical record and the discretion of everything around it are two different problems.
Most articles about executive mental health begin by arguing that leaders are people too. A sitting chief executive already knows that and is not stuck on it. What stops the decision is narrower and more practical: the seat comes with paperwork, counterparties and observers that an ordinary patient does not have, and none of the usual reassurance addresses any of them. A CEO signs documents about themselves every year. A company may hold insurance written on their life. A board discusses their continuity as a governance matter. An assistant sees every hour of the week. None of that is unusual, none of it is sinister, and all of it sits outside the health-privacy rules that people assume are doing the work. Discretion for a chief executive is therefore not one protection. It is a short list of separate surfaces, each with its own mechanism, and each one either handled deliberately or left to chance. The same map applies to the officers sitting around a chief executive, which is why private-pay therapy for legal professionals raises an almost identical set of questions from a general counsel.
Five surfaces that belong to the office, not to the person
The annual officer questionnaire
Directors and officers answer written questions each year so counsel can assemble what the company is required to say about them. The requirement sitting behind that exercise, Item 401 of Regulation S-K, asks for names, ages, positions, five years of business experience, other public-company directorships, family relationships, and involvement in certain legal proceedings reaching back ten years. A diagnosis is nowhere on that list. What the annual cycle builds is a habit of answering personal questions in writing, on a schedule, into a file held by somebody else, and that habit is worth noticing separately from what is actually being asked.
Insurance underwritten on your own life
Key-person cover is written on a named individual rather than on a role. Section 101(j) of the Internal Revenue Code requires that the employee be notified in writing that the policyholder intends to insure their life, told the maximum face amount, informed that the company will be a beneficiary, and that the employee consent in writing before the contract is issued. Underwriting then runs on the applicant, not on the business. The instrument that decides how far any of it reaches into a clinical file is the authorization the applicant signs, which is a document you can read slowly and negotiate rather than a rule imposed on you.
Succession, discussed in a room you are sitting in
Boards talk about continuity because continuity is part of the job, and a chief executive who is also the subject of the discussion occupies an unusual position in it. The question a board is answering is about the readiness of the company. Whether a CEO is receiving treatment for executive burnout is a different question with a different owner. Those two questions get conflated most easily when nobody has said out loud which one is actually on the table, and the conflation is far more damaging than either question would be on its own.
The materiality argument nobody has settled
Whether the health of a chief executive can be material information a public company must disclose is genuinely unsettled, and it has been argued in public for decades without resolution. The line items are much narrower than the debate. Item 5.02 of Form 8-K reaches the departure, resignation, removal, election and appointment of a principal executive officer and certain other named officers, and nothing in it asks for a medical condition. Anyone weighing this against a specific set of facts needs securities counsel rather than an article, and any article that answers it cleanly is overreaching.
The administrative trail nobody regulates
A calendar other people maintain, an assistant who books every hour, a corporate card, an expensed receipt: this is where discretion is most often lost, and none of it is governed by health-privacy rules at all. A recurring hold carrying a clinician's name is visible to everyone with calendar access, and a card statement is read by people whose job is to read card statements. The fix here is administrative rather than legal, it is easy, and it has to be decided before the first appointment rather than discovered after the third.
▶ Research
The most useful distinction in the entire federal structure is one that almost nobody outside the field knows exists. Under 45 CFR 164.508, a covered entity must obtain an authorization for any use or disclosure of psychotherapy notes, subject to a few narrow exceptions, and an authorization for psychotherapy notes may not be combined with any other authorization except another one for psychotherapy notes. That last clause is the protection. It means a general release, the kind that gets signed in a stack of documents for an insurer or an employer or a lender, does not sweep those notes along with everything else. Somebody has to ask for them specifically, on their own form, and you have to agree specifically. For a chief executive weighing what a signature might one day carry, that is worth more than any reassurance about discretion.1
What the mechanism explains
Most exposure is authorized, not compelled
The dramatic scenario is a subpoena. The ordinary one is a signature. Underwriting files, applications and diligence packages move on releases people signed without reading, and the volume of information that travels this way is not comparable to the volume that travels under court process. Slowing down at the signature is the single highest-value habit available to a CEO.
The rules govern custodians, not curiosity
Federal health-privacy rules bind covered entities and their business associates. They do not bind a director who forms an impression, an assistant who notices a pattern in the calendar, or a colleague who saw a name. Nothing in those rules regulates observation, which is precisely why the administrative decisions around care matter as much as the legal ones.
Isolation is the cost of managing all of this alone
Every one of these surfaces pushes a chief executive toward saying less to everyone, which works until it stops working. The clinical value of a confidential setting is not only relief. It is having somewhere to think out loud without consequence, which is the one thing the seat structurally removes and the one thing that cannot be replaced by discretion alone.
Three instruments, and what each one can actually reach
Almost every real disclosure runs through one of three instruments. Knowing which one is in front of you tells you what is actually being asked, who is asking, and what a clinician is permitted to do about it. The three are not interchangeable, and the most common mistake a chief executive makes is treating the first as though it carried the force of the second.
An authorization you sign
Under 45 CFR 164.508, a covered entity may not use or disclose protected health information without a valid authorization, which makes your signature the widest door in the whole structure. Psychotherapy notes sit behind a further wall: an authorization for them may not be combined with any other authorization except one for psychotherapy notes. Treatment generally cannot be conditioned on signing, with narrow stated exceptions. The practical consequence is that most information moves because somebody was asked to sign something in a stack, at speed.
A court order, or a subpoena that is not one
Section 164.512 covers disclosures for which no authorization is required, and it separates these two carefully. A subpoena unaccompanied by a court order permits disclosure only on satisfactory assurances: either that reasonable efforts were made to notify the individual and the time to object has passed, or that reasonable efforts were made to secure a qualified protective order limiting use and requiring return or destruction of the information. A court order is a different matter with a different answer. State law on evidentiary privilege sits on top of all of it and is not uniform.
An evaluation somebody else commissions
An assessment arranged by an employer or a board is not treatment, and it does not carry the confidentiality of treatment. EEOC enforcement guidance permits an employer to require a medical examination of an employee only where it is job-related and consistent with business necessity, met by a reasonable belief based on objective evidence about essential job functions or direct threat. The results go to the entity that commissioned the evaluation. Chief executives who confuse this with therapy discover the difference at the worst possible moment.
§02 / 09 / Telehealth
What private pay actually changes.
Private pay changes the payer layer and leaves everything else exactly where it was. No claim is submitted on a chief executive, no diagnosis is transmitted to an insurer, and no reviewer at a plan decides whether care continues. CEREVITY is direct about the part that does not change: the clinical record still exists, and the legal limits on it are the ones every licensed clinician carries.
The claim is the document that was built to travel
A submitted claim carries a diagnosis code, dates of service, a provider identity and a member identity, and it is designed to move between organizations. That is its function. Once it exists it sits with the payer, with whatever entities administer the plan, and in whatever systems those parties use. Removing the claim removes an artifact that was engineered for transmission, which is why therapy that leaves no insurance record is the first question asked by professionals in every credentialed field, not only by chief executives.
Nobody outside the room is deciding whether care continues
Insurance-funded treatment carries review: a payer forms a view about medical necessity, session counts and continuation, and that view is documented somewhere. Private pay removes that entire apparatus. For a CEO the operational value is not only privacy, it is control of the calendar and the arc of the work, because nothing has to be justified to a third party in order to keep going or to stop.
What private pay does not do, stated plainly
Paying privately does not erase the clinician's record, which exists because clinicians are required to keep records. It does not create a legal privilege stronger than the one that already applies. It does not override a court order, a mandatory report, or a duty-to-protect obligation. Any provider who describes private pay as total anonymity is either being careless or selling something, and a chief executive is entitled to hear the boundary before the first appointment rather than after it.
§03 / 09 / Mechanism
Where confidentiality genuinely stops.
Confidentiality for chief executives stops in four identifiable places: a court order, a subpoena handled under the federal rules, a mandatory report, and a duty-to-protect obligation defined by state law rather than by federal regulation. CEREVITY clinicians name these before a first session, because a CEO deciding whether to begin deserves the boundary in advance rather than during a crisis.
Take the legal instruments first, because they are the ones people imagine. A court order and a subpoena are not the same document and do not produce the same response. Under 45 CFR 164.512, disclosure in response to a subpoena that is not accompanied by a court order is permitted only where the requesting party provides satisfactory assurances: either that reasonable efforts were made to give the individual notice, with documentation that the time to raise an objection has elapsed, or that reasonable efforts were made to secure a qualified protective order that prohibits use of the information outside the proceeding and requires it to be returned or destroyed at the end. That is a real procedural gate, and it is one a clinician who has handled these before knows how to hold. State privilege law also applies and differs by state, which is why the correct question to ask is not whether records can ever be reached but what the clinician's actual process is when a demand arrives.
Mandatory reporting and duty-to-protect obligations are the second category, and they are creatures of state law rather than of federal privacy regulation. The federal rule is permissive rather than mandatory: 45 CFR 164.512 allows a covered entity to disclose where it believes in good faith that the disclosure is necessary to prevent or lessen a serious and imminent threat to the health or safety of a person. What converts that permission into an obligation, and what the obligation requires, is set at state level and varies. Every licensed clinician carries some version of it. Nobody can opt out of it, and any clinician who suggests otherwise is misdescribing their own license. The honest framing for a chief executive is that these obligations exist, they are narrow, they are triggered by safety rather than by embarrassment, and they have nothing to do with a quarterly result or a difficult board meeting.
The third category is the one most likely to catch a CEO by surprise, because it is not a limit on treatment at all. An evaluation commissioned by an employer, a board, or an insurer is a different product with a different client. The evaluator's report goes to whoever commissioned it, and that is the arrangement rather than a failure of it. EEOC enforcement guidance sets the standard for when an employer may require a medical examination of an employee, and treats the resulting information as a confidential medical record with defined recipients, but the entire structure assumes the organization receives something. Treatment is the opposite arrangement: the client is the person in the room. Where the pattern underneath all of this is sustained overwork that no longer responds to time away, the work needed is confidential burnout treatment for senior leaders rather than an assessment somebody else has ordered, and the two should never be allowed to blur.
► Standard advice vs. CEREVITY's approach
Standard therapy
"Assume private pay makes care legally invisible"
CEREVITY
"Ask precisely which record exists, who holds it, and what could reach it"
Standard therapy
"Sign the general release in the diligence stack and move on"
CEREVITY
"Read what the authorization covers, and note what it does not automatically include"
Standard therapy
"Treat an evaluation the company arranged as confidential therapy"
CEREVITY
"Ask who the client is and where the report goes before the first meeting"
| Standard insurance-based therapy | CEREVITY's specialized approach |
|---|---|
| "Assume private pay makes care legally invisible" | "Ask precisely which record exists, who holds it, and what could reach it" |
| "Sign the general release in the diligence stack and move on" | "Read what the authorization covers, and note what it does not automatically include" |
| "Treat an evaluation the company arranged as confidential therapy" | "Ask who the client is and where the report goes before the first meeting" |
A break from the page
The questions belong before the first appointment.
A first inquiry is confidential and commits you to nothing. CEREVITY is a nationwide network of independent licensed clinicians working private-pay across all 50 states, with no claim submitted and no diagnosis on a payer record. If you would rather ask the discretion questions first and decide afterwards, start with a private inquiry.
§04 / 09 / Cases
Common challenges we address.
The chief executive advised never to put anything in writing
The patternSomeone who has absorbed a decade of counsel about email, notes and discoverability, and has generalized it into a rule that covers everything, including their own health. The instinct is sound in its original context and it has quietly removed every avenue of support they had.
What we addressThe work begins by separating the categories rather than arguing with the instinct. Corporate documents and clinical records are held by different parties under different rules with different processes for reaching them. Once that separation is clear, most of what such a leader has been carrying alone becomes ordinary clinical material, and much of it turns out to be therapy for high-stakes anxiety rather than anything to do with disclosure.
The CEO whose entire calendar is maintained by somebody else
The patternA leader with genuine intent to start and no mechanism to do it, because every hour of the week is booked by an assistant, visible to a team, and reconstructable by anyone with access. The obstacle is not ambivalence. It is logistics that nobody has treated as a solvable problem.
What we addressThis gets solved administratively in one conversation: how the hold is labeled, which device is used, which card, whether anything is expensed at all. Care delivered by secure telehealth removes the arrival and the waiting room from the arithmetic entirely. What remains is the ordinary clinical question of what is actually wrong, which for many leaders is treatment when performance stays intact and everything else does not.
§05 / 09 / Methods
Evidence-based treatment approaches.
CEREVITY clinicians match the approach to what is actually presenting rather than to the question that prompted the search. Chief executives who arrive through a discretion question most often bring sustained overwork, anticipatory dread before board and earnings cycles, or a specific event that was never processed, and those three have genuinely different treatment paths.
Cognitive behavioral therapy
Structured work on the link between thought, feeling and behavior, using defined exercises and tasks between sessions. It suits leaders who want a method they can see the shape of and a way to measure whether it is working. For chief executives it is most often applied to sleep that has broken down, to anticipatory anxiety before a recurring event, and to the appraisal habits that turn a normal setback into a referendum on competence.
Acceptance and commitment therapy
Work on the relationship to difficult internal experience rather than on its content, organized around values and committed action. It tends to fit executives who have already tried to reason their way out of the feeling and found that the argument did not move it. The target is not the elimination of pressure, which the role will not permit, but the ability to act deliberately while it is present.
Psychodynamic and exploratory work
Less scripted work that uses the conversation itself as the instrument, examining patterns that repeat across a career rather than a single presenting symptom. This is often where a leader arrives at why credentials never seem to settle the question, because the pattern predates the title and no achievement added since has touched it.
Trauma-focused treatment
Structured approaches aimed at a specific event and how it is stored and processed rather than at general stress. For chief executives the relevant event is frequently occupational: a fatality, a hostile investigation, a collapse, a public accusation. The work is deliberately time-limited and specific, and it is a different undertaking from general support.
Behavioral regulation of sleep, alcohol and recovery
Direct work on the physical substrate that most leaders have degraded before they seek anything else: broken sleep, alcohol used as a switch, travel that removes every recovery habit at once. Progress here often changes the clinical picture faster than anything else, and it is usually the first thing addressed rather than the last.
§06 / 09 / Investment
Understanding the investment in private-pay care.
Private-pay, nationwide, and nothing routed through the company
At CEREVITY, our online individual therapy sessions are structured as a direct investment in your mental agility and overall well-being. The investment includes:
- Licensed mental health professional specializing in confidential private-pay therapy for chief executives
- Evidence-based, one-on-one approaches proven effective for burnout, high-stakes anxiety, and disclosure risk
- Flexible online scheduling including evenings and weekends
- Complete privacy with no insurance involvement or red tape
- Chief executives and senior leaders expertise and understanding
- Outcome tracking and progress measurement
The cost of discretion in care for chief executives going unaddressed
Consider what is at stake when discretion in care for chief executives goes unaddressed:
What paying privately buys, and what it does not
Working outside of insurance means no claim is submitted, no diagnosis is transmitted to a payer, no benefits statement is generated, and no third party reviews whether care should continue. It also means nothing is routed through a company plan, a benefits vendor or an assistance program. What it does not buy is the disappearance of the clinical record, or an exemption from the legal limits described above. View our current rates here: cerevity.com/our-pricing-for-therapy/.
Formats that survive a calendar you do not control
Care is delivered by secure telehealth nationwide across all 50 states, which removes travel, arrival and the waiting room from the equation, and with them the most ordinary exposure that leaders describe. Most work runs in standard 50-minute sessions. Where a subject needs more room than a weekly slot allows, 90-minute sessions carry it better, and for leaders whose weeks cannot hold a reliable recurring appointment, the 3-hour intensive format concentrates the work into a single block that can be scheduled around a quarter rather than inside a week. Payment is direct, and the descriptor on a statement is a question worth asking before the first appointment rather than after.
§07 / 09 / Evidence
What the research shows.
The published rules are narrower and clearer than the anxiety around them. Item 401 of Regulation S-K, which governs what a public company discloses about its directors and executive officers, asks for identity, position, five years of business experience, other directorships, family relationships, and involvement in certain legal proceedings over a ten-year lookback. It does not ask about health. Item 5.02 of Form 8-K reaches the departure, resignation, removal, election and appointment of a principal executive officer and other named officers, and it does not ask for a medical condition either. Item 105 of Regulation S-K requires a registrant to set out the material factors that make an investment speculative or risky, in plain English and specific to that registrant rather than generic, which is where dependence on a small number of people is described as a risk to the business. None of these is a health-disclosure rule. What remains genuinely unsettled is the general materiality question, argued for decades and answerable only against particular facts by securities counsel, which is a different thing from a filing requirement and should not be presented as one.
On the clinical side the structure is equally specific. Under 45 CFR 164.508 a covered entity may not use or disclose protected health information without a valid authorization, psychotherapy notes require their own separate authorization that cannot be bundled with any other, and treatment generally cannot be conditioned on signing one. Under 45 CFR 164.512 a subpoena unaccompanied by a court order permits disclosure only on satisfactory assurances of notice or of a qualified protective order, and disclosure to avert harm is permitted where the entity believes in good faith that it is necessary to prevent or lessen a serious and imminent threat. EEOC enforcement guidance sets the separate standard for employer-required medical examinations of employees, which must be job-related and consistent with business necessity and which produce a report for the organization that asked. Where a company holds insurance on a named executive, Section 101(j) of the Internal Revenue Code requires written notice and written consent before the contract is issued. Four different instruments, four different answers, and not one of them is the blanket promise that people go looking for.
§§ / 09 / Recap
Key takeaways.
Five things to remember
- The claim is the artifact worth removing Private pay eliminates the one document in ordinary treatment that was designed to move between organizations. That is a structural change to the exposure a chief executive carries, not a reassurance about it.
- Signatures move more information than subpoenas do Authorizations signed at speed inside underwriting files and diligence packages account for far more disclosure than legal process ever does. Reading the release slowly is a higher-yield habit than any privacy assurance a provider can offer.
- Psychotherapy notes have their own separate door A general authorization does not sweep psychotherapy notes along with everything else, because federal rules require a standalone authorization for them. That distinction is narrow, real, and almost never explained.
- An evaluation is not treatment and never was Anything a board, an employer or an insurer commissions produces a report for the party that commissioned it. Chief executives should establish who the client is before the first meeting, not afterwards.
- CEREVITY provides this through online individual therapy nationwide, with full privacy through its private-pay concierge network and no insurance involvement.
§08 / 09 / FAQ
Frequently asked questions.
Is therapy completely confidential for a CEO?
Confidentiality for chief executives is strong and it is not absolute, and the difference matters more at this level than at any other. Private-pay care removes the claim, so no diagnosis is transmitted to an insurer and no benefits statement is generated for anyone. The clinical record still exists, because licensed clinicians are required to keep records. Federal rules permit disclosure without authorization in defined situations, including a court order, a subpoena handled with the assurances the regulation requires, and a good-faith belief that disclosure is necessary to prevent or lessen a serious and imminent threat. State law adds mandatory reporting and duty-to-protect obligations that vary between states. A clinician who promises total confidentiality with no limits is describing something that does not exist under any license.
Can a therapist refuse a subpoena?
Subpoenas and court orders are different instruments, and a clinician treating a chief executive should be able to explain the difference without hesitating. Under 45 CFR 164.512, a subpoena that is not accompanied by a court order permits disclosure only where the requesting party gives satisfactory assurances: either that reasonable efforts were made to notify the individual and the time to object has passed, or that reasonable efforts were made to obtain a qualified protective order restricting the use of the information and requiring its return or destruction. A clinician can and often does object, seek instructions, or require that the process be followed properly. State privilege law also applies and is not uniform. The right question to ask before starting is what the clinician's actual process is when a demand arrives.
Is it better to pay for therapy out of pocket as an executive?
Chief executives choose private pay for reasons that are structural rather than emotional. No claim is submitted, so no diagnosis code travels to a payer, no third party reviews whether treatment should continue, and nothing is routed through a plan the company sponsors. The trade is straightforward: the cost is not offset by a benefit, and the exposure that would have come with the offset is not created. For a leader whose primary concern is who could ever see a record, that trade usually resolves quickly. Private pay does not remove the clinician's record or the legal limits every license carries, and any provider suggesting otherwise should be treated with caution.
Does key-person insurance underwriting reach my therapy records?
Key-person cover is underwritten on a named individual, so the underwriting questions are about that person rather than about the company. Section 101(j) of the Internal Revenue Code requires that an employee be told in writing that the policyholder intends to insure their life, be told the maximum face amount, be informed that the company will be a beneficiary, and consent in writing before the contract is issued. What determines how far an insurer can reach into a clinical file is the authorization the applicant signs. Under federal rules an authorization for psychotherapy notes cannot be combined with any other authorization, so those notes are not swept along by a general release. A chief executive should read what is being authorized rather than assume its scope.
Is a CEO's mental health material information that has to be disclosed?
Whether the health of a chief executive is material information for securities purposes is genuinely unsettled and has been debated for decades without a clean answer. What is not in doubt is the narrower question of the line items. Item 5.02 of Form 8-K reaches the departure, resignation, removal, election and appointment of a principal executive officer and certain other officers, and asks nothing about a medical condition. Item 401 of Regulation S-K, which governs what a company says about its directors and executive officers, asks about identity, business experience and certain legal proceedings, not about health. Any conclusion for a specific company and a specific set of facts belongs with securities counsel rather than with a clinician or an article.
Is an evaluation the board arranges the same as therapy?
Evaluations commissioned by a board, an employer or an insurer are a different service with a different client, and chief executives should treat them as such from the first minute. The evaluator's report goes to the party that arranged and paid for it, which is the design of the arrangement rather than a breach of it. EEOC enforcement guidance sets when an employer may require a medical examination of an employee, requiring that it be job-related and consistent with business necessity, with the resulting information kept as a confidential medical record and shared only with defined recipients. Treatment inverts that structure entirely: the client is the person in the room, and nothing is produced for anybody else. Confusing the two is the most consequential mistake available here.
What should a chief executive ask a clinician before booking?
Ask six questions and the picture resolves quickly. What record will exist and how long is it kept. Whether the clinician keeps psychotherapy notes separately, and what that changes. What the actual process is when a subpoena arrives, and whether it has happened before. What the mandatory reporting and duty-to-protect obligations are in the state where the clinician is licensed. Whether anything is submitted to an insurer at any point. How the charge appears on a statement, and what appears in any calendar invitation. A clinician accustomed to working with chief executives will answer all six directly and without defensiveness, and the quality of those answers tells you more than any assurance about discretion.
How does your private-pay pricing structure work?
As a private-pay concierge network, we offer structured investments in your mental health without the restrictions or privacy risks of insurance. You can review our full fee schedule and specific session lengths directly on our website. While this costs more than insurance copays, it provides the flexibility, total privacy, and highly specialized care that standard options cannot offer. View our current rates here.
How do you protect my privacy?
Privacy is foundational to our network. As a private-pay network, your sessions never appear on insurance records or EOBs that could be seen by employers, boards, or family members. We use HIPAA-compliant nationwide telehealth platforms, and you can attend sessions from anywhere with a private internet connection.
§09 / 09 / Begin
Discretion is a set of decisions, not a promise.
If the reason you have not started is exposure rather than doubt, the exposure is worth mapping properly before deciding anything. CEREVITY is a nationwide network of independent licensed clinicians providing confidential, private-pay care across all 50 states. Call (562) 295-6650 or send a private inquiry.
Available by appointment 7 days a week, 8 AM to 8 PM (PST)§§ / Author
About Lucia Hernandez, PhD.
Lucia Hernandez, PhD
Dr. Hernandez is a Licensed Psychologist providing therapy for executives, entrepreneurs, and high-achieving professionals. Her work integrates evidence-based cognitive and psychodynamic approaches with a culturally responsive lens, calibrated to the realities of high-responsibility careers. She sees clients via CEREVITY's nationwide telehealth network. View full bio →
§§ / Sources
References.
- Office of the Federal Register, Electronic Code of Federal Regulations. 45 CFR 164.512: Uses and disclosures for which an authorization or opportunity to agree or object is not required. 2026. ecfr.gov
- Office of the Federal Register, Electronic Code of Federal Regulations. 45 CFR 164.508: Uses and disclosures for which an authorization is required. 2026. ecfr.gov
- U.S. Equal Employment Opportunity Commission. Enforcement Guidance on Disability-Related Inquiries and Medical Examinations of Employees Under the Americans with Disabilities Act. 2000. eeoc.gov
- U.S. Securities and Exchange Commission. Form 8-K: Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. 2025. sec.gov
- Office of the Federal Register, Electronic Code of Federal Regulations. 17 CFR 229.401 (Item 401): Directors, executive officers, promoters and control persons. 2026. ecfr.gov
- CEREVITY. Executive burnout therapy. cerevity.com/executive-burnout-therapy
- CEREVITY. Leadership isolation therapy. cerevity.com/leadership-isolation-therapy
- CEREVITY. High-functioning anxiety and depression therapy. cerevity.com/anxiety-and-depression-therapy
⚠ Crisis resources
If you are experiencing a mental health crisis or having thoughts of suicide, please reach out immediately. 988 Suicide & Crisis Lifeline · Call or text 988 Crisis Text Line · Text HOME to 741741 National Alliance on Mental Illness · 1-800-950-NAMI (6264)
